cis-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate
95%
- Product Code: 148430
CAS:
1431720-86-3
| Molecular Weight: | 204.24 g./mol | Molecular Formula: | C₉H₁₇FN₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD18072719 | |
| Melting Point: | Boiling Point: | 266.1°C at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C, dry and sealed from light |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors and antiviral drugs. Its structural features, including the fluorinated pyrrolidine ring and protected amine group, make it valuable for constructing bioactive molecules with enhanced metabolic stability and target selectivity. Commonly employed in medicinal chemistry for fragment coupling in drug candidates targeting central nervous system disorders and oncology. The cis-configuration and fluorine atom contribute to improved binding affinity and pharmacokinetic properties in final drug compounds.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Yellow Solid |
| Purity (%) | 94.5-100% |
| Infrared Spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿203.50 |
+
-
|
| 250mg | 10-20 days | ฿510.00 |
+
-
|
| 1g | 10-20 days | ฿643.50 |
+
-
|
| 5g | 10-20 days | ฿4,180.00 |
+
-
|
cis-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors and antiviral drugs. Its structural features, including the fluorinated pyrrolidine ring and protected amine group, make it valuable for constructing bioactive molecules with enhanced metabolic stability and target selectivity. Commonly employed in medicinal chemistry for fragment coupling in drug candidates targeting central nervous system disorders and oncology. The cis-configuration and fluorine atom contribute to improved binding affinity and pharmacokinetic properties in final drug compounds.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :